Physician profile
Babar Ali
NPI 1952505877
$9,110.39
in general payments reported to CMS, 2019-2025
37 companies · $1,114 in 2025
The $1,114 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,240 · 2020: $621 · 2021: $900 · 2022: $1,530 · 2023: $1,689 · 2024: $1,015 · 2025: $1,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,436 · Travel and Lodging: $288 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,435.88 |
| Travel and Lodging | $288.33 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $1,565.31 | 2019-2025 | Mcot |
| Cook Medical LLC | $1,191.32 | 2019-2025 | Advance, Zilver Ptx, Zilver Vena |
| Surmodics, INC. | $784.03 | 2023 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Microcatheter, 014, 65cm, Straight, Sublime Microcatheter, 014, 65cm, Angle |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $620.18 | 2019-2025 | Lifevest |
| Medtronic, INC. | $532.99 | 2021-2024 | Micra, Venaseal |
| Boston Scientific Corporation | $472.88 | 2019-2025 | Avvigo Guidance System, Bodyguardian |
| Amgen INC. | $430.74 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $386.25 | 2019-2025 | Diamondback Peripheral, Esprit, Emboshield Nav6 |
| Novartis Pharmaceuticals Corporation | $371.38 | 2019-2025 | |
| Medtronic Vascular, INC. | $315.17 | 2019 | |
| Terumo Medical Corporation | $286.77 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $272.37 | 2019-2025 | Wainua |
| Pfizer INC. | $222.31 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $197.65 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $191.51 | 2019-2021 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Babar Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.